Dopamine and psychotic states: preliminary remarks.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002250:Carbon Radioisotopes; D002415:Cats; D003042:Cocaine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D008774:Methylphenidate / Q000494:pharmacology; D010389:Pemoline / Q000494:pharmacology; D010633:Phenmetrazine / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D011605:Psychoses, Substance-Induced / Q000378:metabolism; D011618:Psychotic Disorders / Q000378:metabolism*; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects; D013045:Species Specificity; D013239:Stereotyped Behavior / Q000187:drug effects; D013881:Thioridazine / Q000494:pharmacology; D014443:Tyrosine / Q000378:metabolism
D002250:Carbon Radioisotopes; D011956:Receptors, Cell Surface; D010868:Pimozide; D008774:Methylphenidate; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D010389:Pemoline; D000661:Amphetamine; D003042:Cocaine; D001058:Apomorphine; D013881:Thioridazine; D004298:Dopamine; D006719:Homovanillic Acid; D010633:Phenmetrazine